Enrique Poradosu
Chief Science & Business Off · Nuvectis Pharma, Inc.
- 2024
- Nov 20, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Enrique Poradosu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marlio Charles Mosseri - $1.87M in NVCT purchases and sales in the last 12 months
- Ron Bentsur - $279K in NVCT purchases and sales in the last 12 months
- Juan Sanchez - $75K in NVCT purchases and sales in the last 12 months
- Matthew L. Kaplan - $64K in NVCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Enrique Poradosu?
Enrique Poradosu is a corporate insider, tracked as Chief Science & Business Off of Nuvectis Pharma, Inc. (NVCT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Enrique Poradosu last file a Form 4?
The only primary Form 4 on record is dated 20 November 2024.
Has Enrique Poradosu been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
